High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Authors
Keywords
Salivary duct carcinoma, Next-generation sequencing, Molecular markers, PIK3CA, ERBB2, EGFR
Journal
Journal of Translational Medicine
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-25
DOI
10.1186/s12967-014-0299-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- PIK3CA Mutations and PTEN Loss in Salivary Duct Carcinomas
- (2013) Christopher C. Griffith et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment
- (2013) Gerald S. Falchook et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes
- (2013) Rajesh R. Singh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Copy Number Amplification of the PIK3CA Gene Is Associated with Poor Prognosis in Non-lymph node metastatic Head and Neck Squamous Cell Carcinoma
- (2012) Toshihito Suda et al. BMC CANCER
- Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer
- (2012) T Ettl et al. BRITISH JOURNAL OF CANCER
- Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment
- (2012) V. Nardi et al. CLINICAL CANCER RESEARCH
- KRAS Mutations in Lung Cancer
- (2012) Niki Karachaliou et al. Clinical Lung Cancer
- Biology and Management of Salivary Gland Cancers
- (2012) David J. Adelstein et al. SEMINARS IN RADIATION ONCOLOGY
- Systemic therapy in the management of metastatic or advanced salivary gland cancers
- (2012) Aymen Lagha et al. Head and Neck Optical Diagnostics Society
- Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review
- (2011) Orit Kaidar-Person et al. MEDICAL ONCOLOGY
- Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas
- (2011) Till Sebastian Clauditz et al. PATHOLOGY
- Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance
- (2010) M. D. Williams et al. CLINICAL CANCER RESEARCH
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Sequencing technologies — the next generation
- (2009) Michael L. Metzker NATURE REVIEWS GENETICS
- Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma
- (2008) R Dahse et al. BRITISH JOURNAL OF CANCER
- Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer
- (2008) Hiroyuki Hamakawa et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer
- (2008) Bhavna Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
- (2008) L.D. Locati et al. ORAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More